Company intelligence / Profile preview

Grassmere Partners

Ownership: Private
Development stage: Other

Overview

Grassmere Partners is a U.S.-based multi-disciplinary private investment firm that deploys capital into high-quality businesses across selected industry sectors and at specific stages of growth. It does not appear to be directly involved as an operator or developer within the life sciences, biotechnology, pharmaceutical, CRO, CMO, or healthcare industries. There are no indications it has its own therapeutic programs, clinical pipeline, platform technologies, manufacturing capabilities, or direct involvement with drug modalities or targets. Its primary business activity is investing rather than developing products.

Industry: Investors

Beyond the preview

Go deeper on Grassmere Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grassmere Partners.

Explore the full profile